Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn what tax lots are in automated investing, why they matter for cost basis and tax reporting, and how to use them to optimize your portfolios.
14,599 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
A landmark Nvidia-backed investment could be a game changer for Nebius shareholders. This in-depth look breaks down w...
Public narratives about famous moments often spark a larger lesson about money. This article uses the idea of terrenc...
As cyber threats rise, sentinelOne's 2026 earnings call will reveal how the company plans to expand its AI-driven pla...
As AI workloads surge, data centers need faster, smarter networking. This piece examines the potential of a predictio...
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
When markets stumble, strong AI leaders can offer both stability and growth. This guide highlights five AI-driven sto...
Waymo’s leadership argues that robotaxis will reframe work rather than eliminate it, highlighting maintenance, fleet ...
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
A January 12, 2026 bill aims to ban lawmakers and families from buying stocks, with public notice and hefty penalties...
Bright Horizons beats earnings estimates but unveils a larger-than-expected 2026 center-closure plan, sending bfam sh...